Ulrich von Andrian
Direktor/Vorstandsmitglied bei Monopteros Therapeutics, Inc.
Profil
Ulrich von Andrian is the founder of Selecta Biosciences, Inc. founded in 2007.
He is currently a Director at Monopteros Therapeutics, Inc.
Aktive Positionen von Ulrich von Andrian
| Unternehmen | Position | Beginn |
|---|---|---|
Monopteros Therapeutics, Inc.
 Monopteros Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Monopteros Therapeutics, Inc. manufactures pharmaceuticals. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Ulrich von Andrian
| Unternehmen | Position | Ende |
|---|---|---|
| CARTESIAN THERAPEUTICS, INC. | Gründer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Selecta Biosciences, Inc.
 Selecta Biosciences, Inc. BiotechnologyHealth Technology Selecta Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. Its portfolio includes pipeline, autoimmune, gene therapy, and biologic therapy. The company was founded by Omid C. Farokhzad, Robert S. Langer Jr., and Ulrich von Andrian on December 10, 2007 and is headquartered in Watertown, MA. | Health Technology |
Monopteros Therapeutics, Inc.
Monopteros Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Monopteros Therapeutics, Inc. manufactures pharmaceuticals. | Health Technology |
